Two weeks after Eli Lilly answered the call to slash prices of its insulin products in the United States, Novo Nordisk has followed suit. On Tuesday, the Danish c...

After a phalanx of pharma companies failed to nix price-fixing allegations in a Pennsylvania district court earlier this month, one generics major has elected to set...

Nonprofit hospitals saw the collective value of their tax exemptions rise from an estimated $23.7 billion in 2019 to $27.6 billion in 2020 thanks in part to “substan...

Pharmacy experts said that the Centers for Medicare & Medicaid Services (CMS) isn't likely to follow the example of the Veterans Health Administration, which yes...

The advantage for Covis’ Makena has always been clear: It was the only drug available to prevent premature birth. But, over time, Makena’s disadvantage also becam...

As Novo Nordisk’s weight loss drug Wegovy makes waves in Hollywood, the craze could soon spread across the pond to the U.K. Novo Nordisk is working to make Wegovy...

Even as Novartis CEO Vas Narasimhan, M.D., works through a companywide restructuring, the chief exec saw his pay decline substantially in 2022 thanks to demerits on ...

Following a report last month that GSK kept quiet for more than four decades about the presence of a potential carcinogen in heartburn drug Zantac, Rep. Rosa DeLauro...

AbbVie's Skyrizi and Rinvoq took the top two spots on February’s TV drug ad spending list, but some new, big names made their way into the top 10.  AbbVie’s immun...